Genetic testing has become a valuable tool in toxicology, offering insights into an individual's genetic predisposition to adverse drug reactions or toxicant exposure. By identifying specific genetic variants, healthcare providers can tailor drug therapies to minimize risks and optimize efficacy. For example, testing for TPMT polymorphisms can guide dosing of thiopurines to prevent myelosuppression.
